BRAF and non-small cell lung carcinoma: Two cell lines of BRAF class 3–mutated NSCLC and available treatment data were identified, both with the BRAFG466V class 3 mutation, which is identical to the mutation found in ADK-14, and without other concurrent driver alteration.